Know Cancer

forgot password

Use of Complementary or Alternative Medicine Practices by Women at Increased Risk for Breast Cancer

18 Years
Not Enrolling
Breast Cancer

Thank you

Trial Information

Use of Complementary or Alternative Medicine Practices by Women at Increased Risk for Breast Cancer

OBJECTIVES: I. Determine the prevalence of complementary or alternative medicine (CAM)
practices among adult women who are enrolled in the Risk Assessment Clinic at the National
Naval Medical Center Breast Care Center and are found to be at increased risk for developing
breast cancer. II. Correlate the use of CAM with individual risk for breast cancer. III.
Define the types of CAM practices used by this study population. IV. Identify reasons why
this study population is using CAM.

OUTLINE: Patients are stratified according to prevalence of complementary and alternative
medicine practices (enteral/parenteral vs psychologic/neurologic). Patients complete a
Personal Risk Assessment form, pre-test/post-test knowledge questionnaires, and a survey

PROJECTED ACCRUAL: A total of 102 patients will be accrued for this study within
approximately 2 years.

Inclusion Criteria

DISEASE CHARACTERISTICS: Enrolled in the Risk Assessment Clinic (RAC) of the National
Naval Medical Center and found to be at increased risk for breast cancer based on at least
one of the following: Estimated risk of at least 1.7% for developing breast cancer over
the next 5 years, as determined by the Breast Cancer Risk Assessment Tool (BCRAT) Prior
history of lobular carcinoma in situ or ductal carcinoma in situ Family history of breast
or ovarian cancer consistent with autosomal dominant pattern of inheritance or empirically
elevated risk of breast cancer based on a single first- or second-degree relative with
breast or ovarian cancer Must have attended the RAC education session within past 3-6
months Hormone receptor status: Not specified

PATIENT CHARACTERISTICS: Age: 18 and over Sex: Female Menopausal status: Not specified
Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not
specified Hepatic: Not specified Renal: Not specified Other: No other prior cancer except
ductal carcinoma in situ or basal cell carcinoma Able to read and understand English


Type of Study:


Study Design:

Primary Purpose: Prevention

Principal Investigator

Paula Glauber, RN

Investigator Role:

Study Chair

Investigator Affiliation:

National Cancer Institute (NCI)


United States: Federal Government

Study ID:




Start Date:

June 2000

Completion Date:

September 2001

Related Keywords:

  • Breast Cancer
  • breast cancer
  • Breast Neoplasms



National Naval Medical Center Bethesda, Maryland  20889
Medicine Branch Bethesda, Maryland  20892